news
Award recognises innovative label-free technology
A Frost & Sullivan award has been given to a new label-free single-cell analysis and sorting platform for utilising cutting-edge technologies.
List view / Grid view
Frost & Sullivan
news
Non-therapeutic applications to add revenue to the global human albumin market
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
news
Drug abuse triggers regulations to push the development of abuse-free opioid formulations
8 June 2015 | By Victoria White
A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
news
Targeted therapies offer novel treatment modalities for breast cancer
19 March 2015 | By Victoria White
While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted therapies is on the rise...
news
Oncologic imaging innovation is enabling earlier detection of cancers
4 February 2015 | By Frost & Sullivan
Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...